(Q35680633)

9 August 2017

1 reference

title

Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy (English)

1 reference

9 August 2017

1 reference

1

J Wouter Jukema

1 reference

9 August 2017

José W A van der Hoorn

series ordinal

2

1 reference

PubMed ID

14996641

9 August 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

Expert Opinion on Pharmacotherapy

9 August 2017

1 reference

9 August 2017

5

1 reference

9 August 2017

2

1 reference

9 August 2017

459-468

1 reference

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

9 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Mechanisms of plaque stabilization for the dihydropyridine calcium channel blocker amlodipine: review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Novel mechanisms of the antiproliferative effects of amlodipine in vascular smooth muscle cells from spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Assessment and treatment of endothelial dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Endothelial function as a determinant of vascular function and structure: a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Inhibition of oxidized LDL aggregation with the calcium channel blocker amlodipine: role of electrostatic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

The hyperlipemic hamster - a model for testing the anti-atherogenic effect of amlodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Effects of the calcium channel blocker amlodipine on serum and aortic cholesterol, lipid peroxidation, antioxidant status and aortic histology in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Reduction in infarct size by chronic amlodipine treatment in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Different effect of antihypertensive drugs on conduit artery endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Atorvastatin reduces interleukin-6 plasma concentration and adipocyte secretion of hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin On Recovery of coronary Endothelial function).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.2.459

21 January 2018

Identifiers

DOI

10.1517/14656566.5.2.459

1 reference

9 August 2017

1 reference

PubMed ID

14996641